Real|World Acute Toxicity and 90|Day Mortality in Patients With ...

Real-World Acute Toxicity and 90-Day Mortality in Patients With ...

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung ...

Real-World Acute Toxicity and 90-Day Mortality in Patients With ...

This nationwide study revealed a low rate of acute toxicity and an acceptable 90-day mortality rate in patients with SBRT-treated stage I NSCLC.

MA03.09 Real-World Acute Toxicity and 90-day Mortality in Patients ...

Conclusions. To the best of our knowledge, this nationwide study represents the largest real-world series of patients with stage I NSCLC with availability of ...

MA03.09 Real-World Acute Toxicity and 90-day Mortality in Patients ...

Conclusions. To the best of our knowledge, this nationwide study represents the largest real-world series of patients with stage I NSCLC with availability of ...

Real-world acute toxicity and 90-day mortality in patients with stage I ...

Notably, advanced age did not increase acute toxicity or mortality risk. Our predictive models, with satisfactory performance, offer valuable ...

Assessing Acute Toxicity and 90-Day Mortality in Stage I NSCLC

Assessing Acute Toxicity and 90-Day Mortality in Stage I NSCLC: A Real-World Appraisal of Stereotactic Body Radiotherapy Outcomes ... J Thorac Oncol. 2024 Nov;19( ...

Real-world acute toxicity and 90-day mortality in patients with stage I ...

Real-world acute toxicity and 90-day mortality in patients with stage I non-small cell lung cancer treated with stereotactic body radiotherapy.

Real-world acute toxicity and 90-day mortality in patients with stage I ...

Cite this ... van Rossum, Peter S N ; Wolfhagen, Nienke ; van Bockel, Liselotte W et al. / Real-world acute toxicity and 90-day mortality in ...

International Association for the Study of Lung Cancer - Facebook

This study aimed to uncover the real-world incidence of acute toxicity & 90-day mortality in SBRT-treated stage I #NSCLC pts & develop ...

Real-world acute toxicity and 90-day mortality in patients with stage I ...

Request PDF | On Jul 1, 2024, Peter S.N. van Rossum and others published Real-world acute toxicity and 90-day mortality in patients with ...

Real-World Acute Toxicity and 90-day Mortality in Patients with ...

Real-World Acute Toxicity and 90-day Mortality in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.

IASLC | This study aimed to uncover the real-world incidence of ...

... real-world incidence of acute toxicity & 90-day mortality in SBRT-treated stage I #NSCLC pts & develop prediction models for these outcomes ...

Assessing Acute Toxicity and 90-Day Mortality in Stage I NSCLC

Assessing Acute Toxicity and 90-Day Mortality in Stage I NSCLC: A Real-World Appraisal of Stereotactic Body Radiotherapy Outcomes.

Real-World Acute Toxicity and 90-Day Mortality in Patients ... - OUCI

Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy. https://doi.org/10.1016/j.jtho ...

Real-World Acute Toxicity and 90-Day Mortality in Patients With ...

Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy · Comments Section.

Adela on X: "Real-World Acute Toxicity and 90-Day Mortality in ...

Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy - Journal of ...

Adela - X

Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy - Journal of ...

Real-world acute toxicity and 90-day mortality in patients with stage I ...

Real-world acute toxicity and 90-day mortality in patients with stage I non-small cell lung cancer treated with stereotactic body ...

Predictive Scoring System for 90-Day Mortality Among Patients With ...

According to our model, a patient with a risk score of 0 would have a 90-day mortality rate of 3.37%, whereas a patient with a risk score of 9 ...

An In-Depth Discussion on Dutch Prediction Models for Relevant ...

Real-world acute toxicity and 90-day mortality in patients with stage I non-small cell lung cancer treated with stereotactic body radiotherapy.